Journal article
PROTEOMICS - Clinical Applications, 2019
APA
Click to copy
Sathe, G., Na, C., Renuse, S., Madugundu, A. K., Albert, M., Moghekar, A., & Pandey, A. (2019). Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease. PROTEOMICS - Clinical Applications.
Chicago/Turabian
Click to copy
Sathe, G., C. Na, S. Renuse, Anil K. Madugundu, M. Albert, A. Moghekar, and A. Pandey. “Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease.” PROTEOMICS - Clinical Applications (2019).
MLA
Click to copy
Sathe, G., et al. “Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease.” PROTEOMICS - Clinical Applications, 2019.
BibTeX Click to copy
@article{g2019a,
title = {Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease},
year = {2019},
journal = {PROTEOMICS - Clinical Applications},
author = {Sathe, G. and Na, C. and Renuse, S. and Madugundu, Anil K. and Albert, M. and Moghekar, A. and Pandey, A.}
}
The aim of this study is to identify the potential cerebrospinal fluid (CSF) biomarkers for Alzheimer's disease and to evaluate these markers on independent CSF samples using parallel reaction monitoring (PRM) assays.